Nausea and vomiting of pregnancy has been a very common age-old phenomenon. Although not well understood, it occurs in almost 70% of pregnant women. While ‘morning sickness’ remains common, it is usually more troublesome when it is serious. The traditional practice of giving the symptomatic antiemetic treatment without much knowledge and confidence, has not changed over the years. The severe end of the continuum, hyperemesis gravidarum, may complicate up to 0.3–2% of pregnancies, causing pathological changes that may affect the mother and fetus. In most cases, affected individuals progress from mild or moderate nausea and vomiting to hyperemesis gravidarum which can be ‘complicated’ or ‘uncomplicated’, the former referring to acetonuria, fluid electrolyte imbalance and Wernicke’s encephalopathy. Prematurity, low birthweight, small for gestational age and a 5-min Apgar score of <7, have been reported in fetuses of mothers affected with hyperemesis gravidarum (level of evidence II–2), more so in women with poor maternal weight gain associated with it.

Etiology

The cause of hyperemesis is still not well understood. The associated risk factors and the significance of these associations are depicted in Table 1. The factors associated with hyperemesis are primarily maternal and fetal factors that are not easily modifiable, but their identification may be useful in determining those women at high risk for developing ahyperemesis and some might give clues on the choice of treatment as in hyperthyroidism and diabetes. High risk for recurrence is observed in women with hyperemesis in the first pregnancy. The risk is reduced by a change in paternity. For women with no previous hyperemesis, a long inter val between births slightly increases the risk of hyper emesis in the second pregnancy. So, relative impact of genetic and environmental factors and their possible interactions is also seen in hyperemesis [1]. A low pre-pregnancy weight to height ratio may predispose women to the development of hyperemesis [2]. Low maternal age and multiparity independently increases the risk for nausea and vomit ing in pregnancy. Smoking before pregnancy and using vitamins in early pregnancy are associated with a decreased risk for nausea and vomiting (level of evidence II–2 [3]). Women working outside the home have a lower rate of nausea and vomiting than housewives and women out of work [4]. Hormonal factors are known to play an important role in the etiology. The cause seems to be associated with higher levels of selected forms of Human Chorionic Gonadotropin (HCG) with the greatest thyroidstimulating capacity. Few isoforms of chorionic gona dotropin act via the Thyroid-Stimulating Hormone (TSH) receptor to accelerate iodine uptake. Also low prolactin levels and high estradiol levels are found to be associated with nausea in pregnancy [5]. Researchers theorized that during human evolution, sickness during pregnancy protected the fetus by making the mother too nauseous to eat foods that were most likely to be toxic in the early pregnancy. Support for this idea comes from the fact that many of the foods that tend to repulse pregnant women contain potentially harmful substances. Also, women who have virtually no nausea or vomiting appear to be more likely to miscarry than those who experience some sickness. Psychological and social factors influence this disease, such as unwanted pregnancies. Young unwed mothers are common sufferers of this syndrome. Remarkable improvement with hospitalization is often noted in such cases, with rapid relapse once released to the home environment. Women with personality disorders are predisposed to this condition (Table 2).

Table 1: Risk Factors for Hyperemesis Gravidarum

Table 2: Factors Associated with Hyperemesis Gravidarum

Recent Developments

Role of Helicobacter Pylori: Recently, an association between the bacterium Helicobacter pylori and hyperemesis gravidarum has been found as serologically positive H. pylori infection has been demonstrated in the hyper emesis group [6]. In this study, Karaca et al. compared 56 pregnant women with hyperemesis gravidarum to 90 pregnant women without hyperemesis and detec ted specific serum immunoglobulin G for H. pylori by the fluorescent enzyme immunoassay method in 82% of subjects of the hyperemesis gravidarum group, suggesting chronic infection, compared with 64% in the controls, the difference being statistically significant. Supporting this, agents active against H. pylori have been found to be very effective for the treatment of hyperemesis [7,8]. The elevated hCG causing a shift in pH along with pregnancy-induced gastrointestinal dysmotility and altered humoral as well as cell-mediated immunity in pregnancy are believed to be the reasons for infection. Lower socioeconomic status may also be an important risk factor of infection with H. pylori in pregnant women with hyperemesis gravidarum [6].

Immunological Factors

The recent reports also significantly correlate the severity of hyperemesis with increased concentrations of cell-free fetal deoxyribonucleic acid (DNA) [9]. Sugito et al. studied 202 pregnant women between 6 and 16 weeks bearing a single male fetus. The clinical severity of hyperemesis was directly associated with the increase in fetal DNA. The fetal DNA comes from the destruction of villous trophoblasts which border the intervillous space filled with maternal blood [10,11]. These are destroyed by the hyper-activated maternal immune system while tolerating the fetus as a graft. The functional activation of natural killer and cytotoxic T cells is found to be more prominent in hyperemesis than in women with an uncomplicated pregnancy [12]. Thus hyper-activation of the maternal immune system may be responsible for the onset of hyperemesis, probably while maternal immune tolerance to the semi-allograft is being established. Various hormonal and immunological factors associated with hyperemesis are depicted in Diagnosis.

Diagnosis

Hyperemesis gravidarum is diagnosed when protracted vomiting is present along with the inability to tolerate solid foods or fluids and the presence of ketonuria.

Although nausea and vomiting are very common symptoms of pregnancy, hyperemesis gravidarum is considered when all other causes of persistent nausea and vomiting (as given in Table 3) such as pyelonephritis, pancreatitis, cholecystitis, hepatitis, appendicitis, gastroenteritis, peptic ulcer disease, thyrotoxicosis, malaria and hyperthyroidism are ruled out as the treatment differs. Epigastric pain and hematemesis should be specifically enquired about, which may be either an effect of prolonged vomiting (Mallory Weiss tear) or suggest other pathology which is causing the symptoms such as peptic ulcer disease. The duration of vomiting is important in assessing the risk of complications, like Wernicke’s encephalopathy as a result of thiamine deficiency, which has been reported from 3 weeks after the onset of symptoms [13-17].

Table 3: Different Diagnosis of Hyperemesis Gravidarum

Examination

Pulse rate and blood pressure along with assessment of hydration from mucous membranes and skin turgor and also abdominal examination for epigastric tenderness, organomegaly, renal angle tenderness and uterine size is required.

Investigations

When available, electrolytes, liver function tests, thyroid function tests, creatinine, blood urea nitrogen, urinalysis mainly for ketonuria and a complete blood count including malaria are some of the investigations that need consideration in the workup of severe hyperemesis gravidarum where starvation and fluid imbalance can be encountered. Initial assess ment can be done with clinical findings and ketonuria (via dipstick method) whereas prolonged symptoms need investigations such as electrolytes, liver and renal function tests, as well as thyroid function tests.

Hyperemesis gravidaram H. G The woman is suffering from hyperemesis gravidarum, this affects only less than 2% of pregnancies, although more than 50% of women report some nausia or Vomiting when pregnant which is called morning sickness.

Definition of hyperemesis gravidarum Severe or protracted vomiting appearing for the first time before the 20th week of pregnancy that is not associated with other coincidential conditions and is of such severity as to require the patient's admission to hospital Causes and 

Risk factors of H.G While there is no proven causes of H. G. anumber of possibilities have been proposed and studied over the years The most recent research points to genetics and the role that the placuta and appetite gines, GDFIS and IGEBP, may play, study implicating these genes noted that more research Into causal (HCCG It relationship has) In also pregnancy proposed Is necessary contribute that rising to levels H.G. of And the Higher Levels of estrogen and progesteron have been suspected to play a role In nausia Symptoms and digestive issues. Other associations include Increase in blood, levels of thy roxing, which has been documented in upto 73% of A. G. cases It Is usually transiet and not considered serious [18].

If the doctor- decides hospitalization they The mainslay of management is adequate and appropriate fluid and electrolytes replacement, Normalsaline (Nad 0 9% 150 mmol/l NG) or Hartmanns solution /Nach 0.0% 131 mmol/ L Na' Is recommended and potassium chloride can be added to the infusion bag as required 08/20-40 mmol, 5% dextrose saline solution and 10% dextrose solution Should be avoided because they can aggravate hyponat.-remia and precipitate wernicke's encephalopathy, Double-strength Saline is also contraindicated, as this may correct the hyponatremia too rapidly and Cause central pontine myelinolysis, Enteral or total parenteral nutrition (TPN). May be required in very severe cases of hyperemes's, this should be administeredin conjunction with advice from senior pharmacist, as careful monitoring Is Theming necessary supplementation is essential as TON has, the high woman concentration should be of given glucose. lots of emotional, Support and reassurance If the hyperemesisto cope and is sensitive intractable fail to exploration respond and the toe of patient the is unable above measures of her pregnancy may be considered termination [19].

Clinical Consequences of Hyperemesis Gravidarum

Physical Effects: The vomiting, discomfort and reduced appetite that accompanies hyperemesis gravidarum interferes with caloric and fluid intake leading to weight loss, dehydration, deteriorating nutritional state and often acid base and electrolyte imbalance. Hyperemesis gravidarum symptoms that persist into the third trimester are associated with a higher incidence of low-birth-weight infants [20-24]. A mild to moderate ketonuria may be seen which reflects metabolism of fatty acids due to inadequate caloric and protein intake. Ketones readily cross the placenta and may impair fetal neuropsychological development [25]. Thiamine (B1) deficiency has been reported in as many as 60% of hyperemesis gravidarum patients [26]. The woman with hyperemesis gravidarum is prone to thiamine deficiency due to the increased demand for glucose metabolism, added to the inability to tolerate adequate food and vitamin/mineral supplements. Glucose metabolism is very active in pregnant woman due to the hypermetabolic state of pregnancy and the developing fetus’s energy needs and rapid tissue production. Thiamine deficiency can result in beri-beri symptoms that include fatigue, loss of appetite, emotional instability, sleep disturbances and abdominal discomfort. Advanced neuropathic manifestations of beri-beri include paresthesias, weakness, tenderness and cramps of the lower extremities. The cerebral progression of thiamine deficiency resulting in Wernicke’s encephalopathy has been reported in 33 cases in the past 20 years. The initiation of dextrose-containing intravenous fluids or aggressive nutrition support, without the provision of thiamine, can precipitate Wernicke’s encephalopathy. Thiamine administration of 100 mg intravenously (IV) or intramuscularly (IM) daily, or enterally if tolerated, has been suggested for any patient with more than 3–4 weeks of emesis. Hyperemesis gravidarum seems to be associated with higher levels of selected forms of hCG with the greatest thyroid-stimulating capacity by acting via the TSH receptor to accelerate iodine uptake. Biochemical thyrotoxicosis is common in hyperemesis gravidarum but the majority of women are clinically euthyroid. When thyroxine or TSH fall outside the normal range then this is termed transient gestational thyrotoxicosis and resolves by the mid-second trimester. Women who are clinically hyperthyroid may have Graves’ disease and should have autoantibodies measured if available. Treatment with antithyroid drugs or beta-adrenergic blockers is only indicated if clinical and biochemical features of hyperthyroidism are apparent. Hyperthyroidism is often overdiagnosed and inappropriately treated in women with hyperemesis gravidarum. Hyperemesis gravidarum can cause a mild increase in liver enzymes (up to four times the upper limit of normal) that return to normal when the hyperemesis gravidarum is successfully treated. Serum amylase may rise up to five times greater than normal, but this is usually salivary and not pancreatic amylase. Excessive retching during hyper emesis gravidarum may lead to esophageal rupture, Mallory Weiss tears, pneumothorax and pneumomediastinum.

Psychosocial Effects

There has long been a presumption that women with hyperemesis gravidarum develop their physical symptoms as a result of psychological or social factors; a review of the literature regarding this found no evidence to support this theory, although it is reported that psychological responses to hyperemesis may contribute to disease severity. A study suggests that the psychological manifestations may be a result of hyperemesis gravidarum rather than the cause. It is likely that hyperemesis involves an interaction of biological, psychological and sociocultural factors. A recent study has devised ‘The Hyperemesis Impact of Symptoms Questionnaire’ as a clinical tool to assess holistically the impact of the physical and psychosocial symptoms of hyperemesis gravidarum on individuals.

Methods

The khanaqin general Hospital did a prospective descriptive research. From July 2021 through July 2022, all pregnant women who attended their first prenatal clinic appointment at the hospital were included in this research. All pregnant women who agreed to participate were questioned by a research assistant using a structured questionnaire prepared in English; for those who could not speak or read English, the questions were translated into their native language.

Inclusion Criteria 

All pregnant women who provided informed consent were included in the analysis. Women who are expecting a single child.

Conditions of Rejection

Recent index pregnancy patients who had emergency surgery for a urinary tract infection, pyelonephritis, or similar condition. Women who are pregnant with more than one baby (molar gestation) at a time. Women who are or were pregnant and received therapy for mental illness or vitamin insufficiency. Women who refused to provide permission were not included in the research. 

Each participant in the research was interviewed after providing verbal informed permission. Biodata, risk variables and HEG problems were all included of the assessment methodology. The surveys did not contain any personally identifying information.

Analyses of Statistics

Using Poisson regression, we compared the yearly HG incidence rates and derived the incidence rate ratio with 95% CI. Logistic regression with generalized estimating equation was used to analyze the relationships between HG and associative factors (age, gravidity, parity, pre-pregnancy BMI, smoking, marital status, socioeconomic status, municipality population, ART, number and sex of fetuses). Univariate analysis factors with P values.10 were included in the multivariate model; however, socioeconomic status was not included because of a large number of gaps in the data. Rare cases of missing data were not filled up with imputed values. In this study, we used odds ratios with 95% confidence intervals to represent our findings. SAS System for Windows (SAS Institute Inc., Cary, NC, USA) version 9.4 was used for the statistical analysis.

The results showed that 44.9% of pregnant women in the study experienced hyperemesis gravidarum. Most of these women (81.4%) belonged to the age group of 21–35, with the average age being 27. Significant risk factors for HEG were having more than one child, having HEG in the past (44.9%) and having a history of HEG in the family (31.6%) (Table 4-6).

Table 4: Age, Parity, Gestational and Number of History of Hyperemesis (n = 150)

Table 5: Comparisons of Pregnant Women with History of HYPEREMESIS and Parity (n = 67)

Table 6: Comparisons of Pregnant Women with History of Hyperemesis and Age Group (n = 67)

The purpose of this study is to prospectively determine the prevalence of NVP among pregnant women up until the end of their pregnancies. Differences in NVP between the first and second trimesters had a statistical power of 100%, while those between the second and third trimesters had a power of 52%. Prevalence estimates of NVP have hitherto concentrated on the first trimester [17-21].

Our results show that NVP are prevalent symptoms in the early stages of pregnancy and that their incidence reduces later in the pregnancy. Consistent with earlier studies published in the worldwide literature [22] and in population [19,20], 63% and 29% of first-trimester pregnancies were affected by NVP. Recent research suggests that NVP often resolve by the end of the second trimester, while in around 15% to 20% of cases they may persist into the third trimester [5].

Two datasets [19,20] corroborate this trend by reporting an uptick in vomiting in the third trimester following a decrease in the second. However, our findings imply that the prevalence and severity of NVP gradually decreases during the course of pregnancy. There are two potential methodological discrepancies that might account for this discrepancy between studies. Since our study is longitudinal, we don't have to worry about referral bias and we already have a questionnaire validated that can tell the difference between symptoms of gastroesophageal reflux and those of nausea and vomiting. We have previously described the trend of Gastroesophageal Reflux Symptoms (GERS) in this cohort, finding that the incidence of GERS is consistent across all three trimesters of pregnancy [13]. Compression and displacement of the fundus by the uterus at the end of pregnancy, as well as an increase in intra-abdominal pressure, may promote GERS [5]. Since GERS and NVP are treated differently, distinguishing between the two is crucial in clinical practise. We have not used any of the current categories (PUQUE/Rhode's score) since they are not appropriate for evaluating the pregnant lady throughout each trimester and only refer to symptoms in the 12 hours before to the interview.

Our research has linked NVP to Latin American ancestry, but only in the early stages of pregnancy. Consistent with our results, a recent prospective study of 2,470 pregnant women found an increased incidence of nausea and vomiting in the first trimester in women of non-Hispanic Black (RR = 4.3, 95%CI: 1.6-11.6) and Hispanic origin (RR = 2.3, 95%CI: 0.4-11.5) ancestry compared to Caucasian ancestry. These variations may be explained by the fact that Latinas in Spain have younger reproductive ages and poorer socioeconomic statuses than women from the rest of the country.

There was a negative correlation between NVP and weight growth during pregnancy. This assertion should be taken with a grain of salt, however, because NVP has been shown to have a negative impact on appetite and food intake, leading to weight loss (or less increase) and nutritional deficiencies, both of which can lead to further symptoms. Similar to what was reported by Ben-Aroya et al., we discovered no statistically significant correlation between pre-pregnancy BMI and NVP. Patients with higher rates of NVP throughout the first trimester (2 or more vomiting episodes per day) had lower body mass indexes (BMIs) to begin with than those who experienced less frequent NVP (0-1 vomiting events per day). Patients who presented to any gynaecological emergency or clinic during the first trimester of pregnancy were included, as opposed to just previously healthy pregnant women in our series.

The occurrence and permanence of NVP may be influenced by psychological variables. Women with a higher psychosomatic score were more likely to report feeling sick in our study sample. This is consistent with research suggesting that stress, somatization and conversion disorders may all have a role in the development of NVP. In addition, they hypothesised that one's emotional reaction to ongoing NVP might worsen the symptomatology.

Maintaining NVP in the second and third trimesters was most strongly predicted by having reported symptoms in the first trimester. This research is the first to identify a persistent nausea and vomiting maintenance cause. There appears to be a biological predisposition in women with NVP to continue experiencing nausea and vomiting far into the third trimester of pregnancy.

In our cohort, the number of prior pregnancies was associated with a modest reduction in the likelihood of experiencing nausea and vomiting during the first trimester. However, other studies have showed that multigravidae, who are more prone to experience these symptoms after the first trimester with each consecutive pregnancy, experience them more frequently. No correlation was found between alcohol and cigarette consumption and vomiting and nausea in our research. However, some studies have shown that prenatal alcohol and cigarette use reduces a woman's likelihood of developing NVP.

Since the hyperemesis gravidarum patient we saw was an outlier, we were unable to generalise our findings. Hyperemesis gravidarum was not linked to maternal age, parity, the number of induced pregnancies, or cigarette smoking, according to a recent study. Furthermore, there was no statistical correlation between hyperemesis gravidarum and the incidence of small-for-gestational-age births, preterm births, gestational diabetes, pregnancy-induced hypertension, caesarean section rate, or bad foetal outcome [6].

The gastroenterologist plays a crucial role in the care of pregnant women with severe hyperemesis and NVP. In all other cases, the care provided by an obstetrician should be sufficient. If the obstetrician feels a secondary gastro-esophageal condition is causing the NVP, or if the NVP are not effectively treated with the conventional medications, the pregnant woman should be sent to a gastroenterologist. Furthermore, given the high frequency of nauseas in our research, we advise pregnancy termination if a general practitioner, gastroenterologist, or gynaecologist makes a diagnosis of nauseas in a young woman without a definite aetiology.

Between 2021 and 2022, there was a yearly rise of one case per 1000 births in Iraq due to HG, bringing the total incidence to 1.3%. Our large-scale research population yielded specific data on HG risk factors. We discovered that HG pregnancies are distinct from both non-HG pregnancies and HG pregnancies among women who have had HG identified in at least one pregnancy. Some factors were consistently associated with higher risk of HG across comparisons, including assisted reproductive technology (ART), female sex of the fetus and multiple gestation, but unexpected inverse associations were found between age and gravidity and HG. Specifically, HG pregnancies that resulted in delivery were more common in younger age groups and the risk of HG increased as gravidity increased when compared with reference women's pregnancies, but when compared with case w These findings all point to a complex basis for HG.

Recommendation

Further studies in future, also complete history, physical examination and investigations are important to establish the diagnosis. Prompt treatment is essential to prevent complications. Pharmacotherapy complement with non-pharmacological treatment successfully controlling most symptoms of hyperemesis gravidarum.

1. Hailemariam, S. et al. “Prevalence of hyperemesis gravidarum and associated factors among pregnant women at jimma university medical center, south west Ethiopia: A cross-sectional study.” EC Gynecology, 2016, pp. 376–387.

2. Hizli, D. “Hyperemesis gravidarum and depression in pregnancy. Is there an association?” Journal of Psychosomatic Obstetrics & Gynecology, vol. 33, no. 4, 2012, pp. 171–175.

3. Rashid, M. “Hyperemesis gravidarum and fetal gender: A retrospective study.” Journal of Obstetrics and Gynaecology, vol. 32, no. 5, 2012, pp. 475–478.

4. Peled, Y. “The Impact of Total Parenteral Nutrition Support on Pregnancy Outcome in Women with Hyperemesis Gravidarum.” Journal of Maternal-Fetal & Neonatal Medicine, vol. 27, no. 11, 2014, pp. 1146–1150.

5. Genecho, K. et al. “Prevalence of hyperemesis gravidarum and associated factors in Arba minch general hospital, Gamo Gofa zone, southern Ethiopia.” Clinical Mother and Child Health Journal, vol. 15, 2018, p. 1.

6. Peled, Y. “The impact of severe hyperemesis gravidarum on the triple test screening results.” Journal of Maternal-Fetal & Neonatal Medicine, vol. 25, no. 6, 2012, pp. 637–638.

7. McCarthy, F. et al. “Hyperemesis gravidarum: Current perspectives.” International Journal of Women’s Health, vol. 6, 2014, pp. 719–725.

8. Hod, M. et al. “Hyperemesis gravidarum: A review.” Journal of Reproductive Medicine, vol. 39, no. 8, 1994, pp. 605–612.

9. Schiff, M.A. et al. “The sex ratio of pregnancies complicated by hospitalization for hyperemesis gravidarum.” BJOG, vol. 111, no. 1, 2004, pp. 27–30.

10. Philip, B. “Hyperemesis gravidarum.” Wisconsin Medical Society, vol. 102, no. 3, 2003, pp. 46–51.

11. Fejzo, M. “High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals.” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 141, no. 1, 2008, pp. 13–17.

12. Ghadah, A. “Prevalence and risk factors of hyperemesis gravidarum among egyptian pregnant women at the woman’s health center.” Medical Journal of Cairo University, vol. 80, no. 2, 2012, pp. 161–168.

13. Murphy, G.T. “Secular trends in the treatment of hyperemesis gravidarum.” American Journal of Perinatology, vol. 25, no. 3, 2008, pp. 141–147.

14. Sadaf, T. “Management of hyperemesis gravidarum using steroid therapy.” Journal of Rawalpindi Medical College, vol. 16, no. 1, 2012, pp. 59–61.

15. Tilahun, K. “Assessment of nausea and vomiting of pregnancy on antenatal clients of Addis Ababa.” Ethiopian Journal of Health Development, vol. 27, no. 3, 2013.

16. Chigero, W. et al. “Incidence of nausea and vomiting of pregnancy among Nigerian women.” Scholars Journal of Applied Medical Sciences, vol. 2, no. 10, 2014, pp. 413–421.

17. Fiaschi, L. et al. “Hospital admission for hyperemesis gravidarum: A nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies.” Human Reproduction, vol. 31, no. 8, 2016, pp. 1675–1684.

18. Veenendaal, M.V. et al. “Consequences of hyperemesis gravidarum for offspring: A systematic review and meta-analysis.” International Journal of Obstetrics and Gynaecology, vol. 118, no. 11, 2011, pp. 1302–1313.

19. Morokuma, S. et al. “Relationship between hyperemesis gravidarum and small-for-gestational-age in the japanese population: The Japan environment and children’s study (JECS).” BMC Pregnancy and Childbirth, vol. 16, no. 1, 2016, p. 247.

20. David, M. et al. “Do immigration and acculturation have an impact on hyperemesis gravidarum? Results of a study in Berlin/Germany.” Journal of Psychosomatic Obstetrics & Gynecology, vol. 33, no. 2, 2012, pp. 78–84.

21. Aminu, M.B. et al. “Prevalence of hyperemesis gravidarum and associated risk factors among pregnant women in a tertiary health facility in northeast, Nigeria.”

22. Nurmi, M. et al. “Incidence and risk factors of hyperemesis gravidarum: A national register-based study in Finland, 2005–2017.”

23. Nithiyasri, P. et al. “Prevalence and risk factors of hyperemesis gravidarum: A retrospective study.”

24. Sonkusare, S. Hyperemesis Gravidarum. Gynecology for Less-Resourced Locations.

25. Coronado, P.J. et al. “Prevalence and persistence of nausea and vomiting along the pregnancy.”

26. “Determinants of hyperemesis gravidarum among pregnant women attending antenatal care at public and private hospitals in bahir dar city, north-west Ethiopia, 2022: A multicenter unmatched case control study.